Uploaded July 2021 | Updated September 2026, 1 week ago
Drug development expert Dr. Burt Adelman and College of the Atlantic trustee Will Thorndike join the COA 2021 Coffee and Conversation series with a discussion about drug innovation.
While the COVID-19 pandemic placed unprecedented strain on many aspects of our healthcare systems, it also shepherded in life-saving innovation in record time. The mumps vaccine took four years to develop; the first coronavirus vaccine entered a Phase I clinical trial within 10 weeks of the release of the genetic sequence for the virus. Dr. Burt Adelman, an expert in drug development, speaks about medical innovation and the risks in bringing new solutions to fruition. Speaking with Adelman is COA trustee Will Thorndike.
Drug development expert Dr. Burt Adelman and College of the Atlantic trustee Will Thorndike join the COA 2021 Coffee and Conversation series with a discussion about drug innovation.
While the COVID-19 pandemic placed unprecedented strain on many aspects of our healthcare systems, it also shepherded in life-saving innovation in record time. The mumps vaccine took four years to develop; the first coronavirus vaccine entered a Phase I clinical trial within 10 weeks of the release of the genetic sequence for the virus. Dr. Burt Adelman, an expert in drug development, speaks about medical innovation and the risks in bringing new solutions to fruition. Speaking with Adelman is COA trustee Will Thorndike.
